Mirabegron versus darifenacin: which is the preferred first-line treatment for overactive bladder syndrome?

Introduction According to the International Continence Society, overactive bladder (OAB) is defined as urinary urgency, usually with urinary frequency and nocturia, with or without urgency urinary incontinence. Urinary tract infection must have been previously ruled out1,2. OAB is predominant in the African-American race and in the female sex3–5. It presents a 30% prevalence in patients […]